SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-007302
Filing Date
2023-03-09
Accepted
2023-03-09 16:17:35
Documents
5
Effectiveness Date
2023-03-09

Document Format Files

Seq Description Document Type Size
1 S-8 prime-sx8final.htm S-8 74100
2 EX-FILING FEES primes-8ex107filingfeetabl.htm EX-FILING FEES 26242
3 EX-5.1 primes-8x51opinionfinal.htm EX-5.1 8076
4 EX-23.1 prme-sx8consentfinal.htm EX-23.1 1799
5 logoa.jpg GRAPHIC 14883
  Complete submission text file 0001628280-23-007302.txt   126381
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270400 | Film No.: 23719978
SIC: 2836 Biological Products, (No Diagnostic Substances)